US Patent Issued to The Government of the United States, as Represented by the Secretary of the Army on March 17 for "Crimean-Congo hemorrhagic fever virus M-segment nucleic acid vaccine and methods of use and production" (Maryland, Virginia Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,145, issued on March 17, was assigned to The Government of the United States, as Represented by the Secretary of the Army (Ft. Detrick, Md.).

"Crimean-Congo hemorrhagic fever virus M-segment nucleic acid vaccine and methods of use and production" was invented by Aura R. Garrison (Knoxville, Md.), Charles J. Shoemaker (Stephens City, Va.) and John J. Suschak III (Damascus, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus that causes severe hemorrhagic fever disease in humans. Currently, no licensed CCHF vaccines exist, and the protective epitopes remain unclear. Here, we tested a ...